Alcoa Corp (NYSE:AA) is scheduled to report earnings after the close on Thursday, July 16.
MXL's operating momentum is improving, but a 411.7% year-to-date surge and premium valuation leave less room for execution missteps.
RiverNorth Opportunities Fund Inc. manages $324M in net assets with a diversified portfolio spanning SPACs, US equity, bonds, and BDCs. RIV trades at a 4% discount to NAV, near its 5-year average, and sits at one of its lowest historical points. The fund's 5-year NAV total return is 6.25%, underperforming its peer group, with moderate correlation to broad allocation ETFs.
Jefferies has upgraded Shopify Inc (TSX:SH., NYSE:SHOP) to Buy from Hold and bumped its price target up to $160, pointing to strong early signs for the second quarter, a reworked partner program, and what it thinks is a price increase on the way.
MXL's optics ramp and AI-linked demand strengthen its growth outlook, but uneven broadband trends and cash-flow pressure keep execution in focus.
Ripple's highly regulated RLUSD stablecoin is seeing some adoption beyond payments. Recently, it helped to fund an initiative that it meant to support US businesses that are owned by military veterans and their spouses.
Cardano founder Charles Hoskinson has publicly dismissed rumors that he is preparing to step away from the blockchain project.
Aave has expanded its use of Chainlink's Cross-Chain Interoperability Protocol (CCIP), making it the default infrastructure for cross-chain activity across its ecosystem.
Franco-Nevada Corporation might have remained unmoved YTD, but with the current gold price weakness, even that means it has outperformed gold mining peers. A combination of its business model, prospects for the remainder of 2026 and market multiples contribute to FNV's relatively better performance. I assign a Buy rating, citing robust fundamentals, upside to historical P/E averages, and resilience despite gold's recent weakness.
The new venture will develop stablecoin, tokenization, settlement, and payment infrastructure for institutions in Japan.
U.K.-based remittance provider ACE Money Transfer has launched a cross-border payments partnership with Visa. The collaboration will see the companies promote account funding transactions to support faster and more seamless money transfers, ACE said in a Monday (July 13) news release.
Cohen & Steers, Inc. (CNS) is rated BUY, driven by strong fund inflows, accelerating REIT performance, and a 37% forward P/E discount versus historical peaks. Cohen & Steers' AUM reached $93 billion in Q1 2026, with 86% of AUM outperforming benchmarks over one year and 98% over three years. REITs, comprising 48% of AUM, are benefiting from sector rotation, improved property fundamentals, and have delivered double-digit YTD returns.
AppLovin (NASDAQ:APP | APP Price Prediction) is getting hammered Monday, sliding 12%.
A lack of spot buying pressure indicated XRP could soon fall below the $1 round-number level.
SpaceX (SPCX) has been trading publicly for a month now, and shares have since fallen below the company's IPO price. Luke Lloyd expects downside pressure to continue toward $100.
A deluge of hyperscaler debt creates risk that investors will run up against concentration limits in their portfolios from a single company or industry.
Delta Air Lines Inc (NYSE:DAL) reaffirmed its full-year earnings outlook despite higher fuel costs, a move Bank of America said underscores the carrier's earnings resilience and supports its valuation following stronger-than-expected second quarter results. Bank of America maintained its ‘Buy' rating on Delta after the airline reported second-quarter earnings per share above consensus, with the beat driven by lower-than-expected costs while revenue was broadly in line with expectations.
Tempus AI, Inc. earns a Strong Buy rating due to its transformation into a healthcare data giant with high-margin, rapidly growing data services. TEM's Q1 2026 data segment revenue surged 40% YoY to $87M, with robust bookings and visibility, positioning the segment for $500M+ revenue in 2026. MRD testing volume rose 500% YoY, driven by a highly sensitive, reimbursed test partnership with Personalis, fueling valuable data acquisition for pharma clients.
Google maintained steady user and traffic growth in June while rivals Claude and Gemini extended sharp gains, according to a new note from Bank of America. BofA reiterated its Buy rating on Alphabet Inc (NASDAQ:GOOG), pointing to comments from Google executives describing an "expansionary moment" for Search that could support continued strength into 2026.
Eaton trades near its 52-week high as data center demand, acquisitions and growth investments support upside, though its valuation calls for patience.
Apple's stock has rallied to record highs recently. Some experts say they believe it still has has more room to run.
Amazon is launching Amazon Supply Chain Services, leveraging its logistics infrastructure for external customers beyond its core e-commerce, AWS, and advertising businesses. ASCS targets residential parcel delivery, offering lower rates and simpler pricing to attract third-party volume, improving network utilization and operational efficiency. Base and strong case scenarios suggest ASCS could contribute 2–5% of annualized operating income, with the primary benefit being cost savings in Amazon's retail logistics.
Apple‘s (NASDAQ:AAPL | AAPL Price Prediction) stock has climbed 15% since June 25, adding $600 billion in market value, pushing shares to $317.18 and right up against the 52-week high of $323.45.
Bloom Energy's 12% gain in three months, AI data-center demand and robust growth forecasts offset concerns over its premium valuation.
Progressive enters Q2 earnings season with higher premiums and investment income poised to offset rising costs, and a projected year-over-year profit decline.
The US Food and Drug Administration's finalized guidance on psychedelic drug development signals the agency remains receptive to helping developers navigate the approval process, a development that Jefferies said could benefit companies including Compass Pathways (NASDAQ:CMPS), AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC), Cybin Inc. (NYSE-A:CYBN, FRA:R7E), GH Research (NASDAQ:GHRS), Awakn Life Sciences (NEO:AWKN) and others in the sector. The firm wrote on Monday that the final guidance, alongside the FDA's plans to hold a public hearing on September 14, points to a more supportive regulatory environment that could reduce regulatory risk for psychedelic drug developers.
The second-quarter earnings season—banks kick it off tomorrow—could be the catalyst that powers the stock market higher.
Ripple's CSSF CASP authorisation reveals how MiCA's July 2026 deadline has divided Europe's crypto market into licensed operators and those forced to exit.
CHCI expands Reston Station's tech tenant base with Virtualitics' 3,000-square-foot lease, which, in turn, is likely to expand the company's Northern Virginia footprint.
ELV faces Q2 pressure as weaker Health Benefits results and higher benefit expenses may weigh on earnings ahead of its July 15 report.